Mediastinal cryobiopsy: safe and effective but in whom and when?
- PMID: 36279883
- DOI: 10.1016/S2213-2600(22)00410-6
Mediastinal cryobiopsy: safe and effective but in whom and when?
Conflict of interest statement
LKT reports grants, in-kind support, and honoraria from Erbe Elektromedizin, Boehringer Ingelheim, and Hoffmann La Roche. JPW reports speaker's honoraria from Pfizer and AstraZeneca.
Comment on
-
Transbronchial needle aspiration combined with cryobiopsy in the diagnosis of mediastinal diseases: a multicentre, open-label, randomised trial.Lancet Respir Med. 2023 Mar;11(3):256-264. doi: 10.1016/S2213-2600(22)00392-7. Epub 2022 Oct 22. Lancet Respir Med. 2023. PMID: 36279880 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
